By Cara Murez HealthDay Reporter THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have one other alternative if they need a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration accredited Novavax Inc.’s protein-based vaccine as a primary booster dose. Until now, it had solely been accredited as a two-dose main […]
Editor’s be aware: This story was up to date at 4:20 p.m. March 29, 2022 — The FDA in the present day approved Americans over the age of fifty to obtain a second COVID-19 booster shot, although many high infectious illness consultants questioned the necessity earlier than the company’s choice. The FDA granted emergency use […]
Dec. 23, 2021 — The FDA has granted emergency use authorization to Merck’s antiviral drug to deal with adults with gentle to reasonable COVID-19 who’re in danger for extreme illness. Similar to FDA authorization of one other antiviral capsule routine — ritonavir plus nirmatrelvir, or Paxlovid — granted to Pfizer on Wednesday, molnupiravir (model identify […]